The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma

Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease

(2014) A. D. Campos-Parra et al.   EUROPEAN RESPIRATORY JOURNAL

Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival

(2014) Jung-Jyh Hung et al.   JOURNAL OF CLINICAL ONCOLOGY

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features

(2014) Yunjian Pan et al.   LUNG CANCER

Comprehensive molecular profiling of lung adenocarcinoma

(2014) Eric A. Collisson et al.   NATURE

Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

(2014) E. C. de Bruin et al.   Cancer Discovery

Histologic Features Associated With Metastatic Potential in Invasive Adenocarcinomas of the Lung

(2013) Lauren Xu et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma

(2013) Jung-Jyh Hung et al.   ANNALS OF SURGERY

Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data

(2013) H. Sakurai et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma

(2013) Tatsuya Yoshida et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome

(2013) Min Jae Cha et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

(2013) Prudence A. Russell et al.   Journal of Thoracic Oncology

Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis

(2012) Y. Zhang et al.   CLINICAL CANCER RESEARCH

RETFusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer

(2012) Rui Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

(2012) Arne Warth et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

(2012) Akihiko Yoshizawa et al.   Journal of Thoracic Oncology

Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases

(2012) Tetsukan Woo et al.   PATHOLOGY INTERNATIONAL

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

(2011) Prudence A. Russell et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

The New Lung Cancer Staging System

(2009) Frank C. Detterbeck et al.   CHEST